Changing practice: Red blood cell typing by molecular methods for patients with sickle cell disease

Transfusion

Volumn 55, Issue 6, 2015, Pages 1388-1393

  Casas, Jessica ^a   Friedman, David F ^a   Jackson, Tannoa ^a   Vege, Sunitha ^b   Westhoff, Connie M ^b   Chou, Stella T ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ERYTHROCYTE ANTIGEN;

ADULT; ALLELE; ANTIGEN EXPRESSION; ARTICLE; BLOOD GROUP TYPING; CHILD; ERYTHROCYTE; FEMALE; GENE SEQUENCE; GENOTYPE; HEMAGGLUTINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR TYPING; PHENOTYPE; SEROLOGY; SICKLE CELL ANEMIA; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; ANEMIA, SICKLE CELL; BLOOD; BLOOD TRANSFUSION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; INFANT; METABOLISM; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; ERYTHROCYTES; FEMALE; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; MALE; MOLECULAR TYPING; RETROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 84931559742     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12987     Document Type: Article

References (27)

1. Chou ST, Liem RI, Thompson AA,. Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol 2012; 159: 394-404.
2. Yazdanbakhsh K, Ware RE, Noizat-Pirenne F,. Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood 2012; 120: 528-537.
3. Chou ST, Jackson T, Vege S, et al. High prevalence of red blood alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013; 122: 1062-1071.
4. Noizat-Pirenne F, Tournamille C,. Relevance of RH variants in transfusion of sickle cell patients. Transfus Clin Biol 2011; 18: 527-535.
5. Silvy M, Tournamille C, Babinet J, et al. Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti Rh linked to partial Rh phenotype. Haematologica 2014; 99: e115-117.
6. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990; 322: 1617-1621.
7. O'Suoji C, Liem RI, Mack AK, et al. Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer 2013; 60: 1487-1491.
8. Afenyi-Annan A, Willis MS, Konrad TR, et al. Blood bank management of sickle cell patients at comprehensive sickle cell centers. Transfusion 2007; 47: 2089-2097.
9. Osby M, Shulman IA,. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories. Arch Pathol Lab Med 2005; 129: 190-193.
10. Jungbauer C, Hobel CM, Schwartz DW, et al. High-throughput multiplex PCR genotyping for 35 red blood cell antigens in blood donors. Vox Sang 2012; 102: 234-242.
11. Hashmi G, Shariff T, Seul M, et al. A flexible array format for large-scale, rapid blood group DNA typing. Transfusion 2005; 45: 680-688.
12. Denomme GA, Van Oene M,. High-throughput multiplex single-nucleotide polymorphism analysis for red cell and platelet antigen genotypes. Transfusion 2005; 45: 660-666.
13. Westhoff CM,. Molecular testing for transfusion medicine. Curr Opin Hematol 2006; 13: 471-475.
14. Avent ND, Martinez A, Flegel WA, et al. The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother 2009; 36: 162-167.
15. Brown DJ,. A rapid method for harvesting autologous red cells from patients with hemoglobin S disease. Transfusion 1988; 28: 21-23.
16. Reid ME, Lomas-Francis C, Olsson ML,. The blood group antigen facts book. 3rd ed. San DIego (CA): Elsevier Academic Press; 2012.
17. Tournamille C, Le Van Kim C, Gane P, et al. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998; 92: 2147-2156.
18. Westhoff CM, Vege S, Wylie DE, et al. The JAL antigen (RH48) is the result of a change in RHCE that encodes Arg114Trp. Transfusion 2009; 49: 725-732.
19. Wester ES, Storry JR, Olsson ML,. Characterization of Jk(a+(weak)): a new blood group phenotype associated with an altered JK∗01 allele. Transfusion 2011; 51: 380-392.
20. Billingsley KL, Posadas JB, Moulds JM, et al. A novel JK null allele associated with typing discrepancies among African Americans. Immunohematology 2013; 29: 145-148.
21. Tournamille C, Colin Y, Cartron JP, et al. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10: 224-228.
22. Tournamille C, Meunier-Costes N, Costes B, et al. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Transfusion 2010; 50: 13-19.
23. Hashmi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion 2007; 47: 736-747.
24. Kappler-Gratias S, Peyrard T, Beolet M, et al. Blood group genotyping by high-throughput DNA analysis applied to 356 reagent red blood cell samples. Transfusion 2011; 51: 36-42.
25. Ribeiro KR, Guarnieri MH, da Costa DC, et al. DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen-matched blood in patients with sickle cell disease. Vox Sang 2009; 97: 147-152.
26. Bakanay SM, Ozturk A, Ileri T, et al. Blood group genotyping in multi-transfused patients. Transfus Apher Sci 2013; 48: 257-261.
27. Miller ST, Kim HY, Weiner DL, et al. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Transfusion 2013; 53: 704-709.